Procoagulant inhibitory properties of paclitaxel poliglumex

Procoagulant inhibitory properties of paclitaxel poliglumex

John Nemunaitis1,2,3, Neil Senzer1,2,3, Barry Cooper2,3, Michael Nemunaitis1, Cynthia Bedell1, Jack W Singer4, Fred B Oldham41Mary Crowley Cancer Research Centers, Dallas, TX, USA; 2Baylor Sammons Cancer Center, Dallas, TX, USA; 3Texas Oncology, Dallas, TX, USA; 4Cell Therapeutics, Inc., Seattle, WA...

Full description

Bibliographic Details
Main Authors:	John Nemunaitis, Neil Senzer, Barry Cooper, et al
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-12-01
Series:	International Journal of General Medicine
Online Access:	http://www.dovepress.com/procoagulant-inhibitory-properties-of-paclitaxel-poliglumex-a5909

Similar Items

by: Yuqiao Shen, et al.
Published: (2008-04-01)

Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy
by: Yuqiao Shen, et al.
Published: (2008-01-01)

Procoagulant properties of human MV3 melanoma cells
by: D.L.A. Geaquinto, et al.
Published: (2008-02-01)

Procoagulants, coagulopathy and prostate cancer
by: Adamson, Andrew Stephen
Published: (1992)

Procoagulant constituents from Cordyceps militaris
by: Juanjuan Zhang, et al.
Published: (2018-12-01)

Impact of Epicatechin on the Procoagulant Activities of Microparticles
by: Thomas Sinegre, et al.
Published: (2020-09-01)

Evaluation Procoagulant Activity and Mechanism of Astragalin
by: Changqin Li, et al.
Published: (2020-01-01)

Procoagulant and Anticoagulant Factors in Childhood Hypothyroidism
by: Nevin Kilic, et al.
Published: (2012-01-01)

Role of platelets in the procoagulant environment in blood
by: Appleby, Jackie A.
Published: (2006)

Characterisation and studies of T-lymphoblastoid procoagulant activity
by: Pickering, William Maxwell
Published: (2004)

Procoagulant signalling in lung injury and fibrosis
by: Smoktunowicz, N.
Published: (2014)

Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy
by: Yuqiao Shen, et al.
Published: (2008-01-01)

Airway procoagulant activity and inflammation in moderate and severe asthma
by: Brims, Fraser John Hall
Published: (2008)

Procoagulant and Antimicrobial Effects of Chitosan in Wound Healing
by: Chih-Hsin Wang, et al.
Published: (2021-06-01)

Procoagulant Phosphatidylserine-Exposing Platelets in vitro and in vivo
by: Emily C. Reddy, et al.
Published: (2020-03-01)

Structural requirements for the procoagulant activity of nucleic acids.
by: Julia Gansler, et al.
Published: (2012-01-01)

The procoagulant effects of fine particulate matter <it>in vivo</it>
by: Pitz Mike, et al.
Published: (2011-03-01)

Procoagulant platelets: Generation, characteristics, and therapeutic target
by: Chu, Y., et al.
Published: (2021)

Proteomic analysis reveals procoagulant properties of cigarette smoke-induced extracellular vesicles
by: Birke J. Benedikter, et al.
Published: (2019-12-01)

Factor VIII in health and disease - the relationship of VIII procoagulant (VIII:C) to VIII procoagulant antigen (VIII:CAg) in selected states
by: McLellan, David Sinclair
Published: (1985)

Studies of leukocyte procoagulant and its role in blood coagulation /
by: Kociba, Gary James
Published: (1971)

Elevated levels of procoagulant plasma microvesicles in dialysis patients.
by: James O Burton, et al.
Published: (2013-01-01)

Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia
by: Alessandro Aliotta, et al.
Published: (2020-12-01)

Procoagulant Disorders in Patients with Newly Diagnosed Pancreatic Adenocarcinoma
by: Renata Talar-Wojnarowska, et al.
Published: (2020-12-01)

Procoagulants and anticoagulants in fetal blood. A literature survey.
by: Waldemar Uszyński, et al.
Published: (2010-05-01)

Modeling and simulation of procoagulant circulating tumor cells in flow
by: Angela eLee, et al.
Published: (2012-09-01)

Regulation of the procoagulant activity of platelets and platelet-derived microparticles
by: Hamali, Hassan A. A.
Published: (2011)

Procoagulant Phospholipids and Tissue Factor Activity in Cerebrospinal Fluid from Patients with Intracerebral Haemorrhage
by: Patrick Van Dreden, et al.
Published: (2014-01-01)

Changes in procoagulant activity during pregnancy in women with drug addiction
by: Л. В. Суслікова, et al.
Published: (2020-05-01)

Thrombocytopathies: Not Just Aggregation Defects—The Clinical Relevance of Procoagulant Platelets
by: Alessandro Aliotta, et al.
Published: (2021-02-01)

Effects of hemocoagulase agkistrodon on the coagulation factors and its procoagulant activities
by: Li H, et al.
Published: (2018-05-01)

The Procoagulant Activity of Apoptotic Cells Is Mediated by Interaction with Factor XII
by: Aizhen Yang, et al.
Published: (2017-09-01)

Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity.
by: Xavier Stephenne, et al.
Published: (2012-01-01)

Dasatinib Inhibits Procoagulant and Clot Retracting Activities of Human Platelets
by: Ildikó Beke Debreceni, et al.
Published: (2019-10-01)

Investigation of procoagulant activity in extracellular vesicles isolated by differential ultracentrifugation
by: Thøger Nielsen, et al.
Published: (2018-12-01)

Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster?
by: Hopkins Paul N, et al.
Published: (2007-12-01)

Modulation of Diverse Procoagulant Venom Activities by Combinations of Platinoid Compounds
by: Vance G. Nielsen
Published: (2021-04-01)

Changes in procoagulant and anticoagulant factors in patients with hepatitis B cirrhosis
by: DENG Yongdong
Published: (2019-02-01)

Novel free paclitaxel-loaded poly(L-&gamma;-glutamylglutamine)&ndash;paclitaxel nanoparticles
by: Danbo Yang, et al.
Published: (2011-01-01)

Increased activity of procoagulant factors in patients with small cell lung cancer.
by: Shona Pedersen, et al.
Published: (2021-01-01)